Facts about Mounjaro (tirzepatide) for weight loss
In September of 2022 the medical journal Cardiovascular Diabetology reported that Mounjaro (tirzepatide) was found to be effective in treating both diabetes and obesity. It was designed to act like a key fitting locks in the pancreas. These locks also exist in the brain, regulating our appetite. Five studies of diabetic patients showed that tirzepatide not only improved blood sugar levels in diabetic patients, but reduced their body weight by 5.4 to 11.7 kg (12 to 26 pounds). In 2022, the FDA granted a so-called fast track designation to Mounjaro for approval for weight loss in patients with obesity.
Further research that tested Mounjaro’s ability to produce weight loss in people with obesity who do not have diabetes, found that the 15 mg dose of Mounjaro was associated with an average body weight reduction of 20.9% over 72 weeks. Another study that tested Mounjaro’s ability to produce weight loss in people with obesity who also have diabetes, the 15 mg dose of Mounjaro was associated with an average body weight reduction of 14.7% over 72 weeks. Mounjaro can be prescribed by physicians for weight loss purposes.
How to Obtain Mounjaro
Mounjaro (tirzepatide) must be prescribed by a physician or other licensed prescriber. QuickMD can prescribe Mounjaro online if it is found to be beneficial for the patient.
What does Mounjaro cost?
The price of Mounjaro ranges from $966 to $1,037 for a one-month supply (4 injections).